Home » Topics » BioWorld Science

BioWorld Science
RSS

Gfap-targeted ASO therapy shows efficacy in rat model of Alexander disease

Dec. 7, 2021

SRI-42127 attenuates glial activation in a model of LPS-induced neuroinflammation

Dec. 7, 2021

RTX-N109D, a rituximab variant with lower sensitivity to CA125 mediated immunosuppression

Dec. 7, 2021

Newly identified variant has large effects on two aspects of cardiovascular risk

Dec. 3, 2021

Novavax outlines vaccine response to SARS-CoV-2 Omicron variant

Dec. 3, 2021

Soligenix's bivalent thermostabilized vaccine protects NHPs against Sudan ebolavirus challenge

Dec. 3, 2021

Novel cyanobacterium-based approach for the treatment of colon cancer and colitis

Dec. 3, 2021

CRISPRa-mediated SEC23A activation rescues SEC23B-deficient CDAII in vivo

Dec. 3, 2021

Novel selective c-Abl inhibitor prevents neurodegeneration in models of Parkinson's

Dec. 3, 2021

BCL10/MALT1 axis found to be involved in psoriasis

Dec. 3, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Medtronic bolsters pain portfolio in $650M SPR Therapeutics buy
BioWorld
Medtronic plc is strengthening its pain management portfolio with its $650 million move to buy SPR Therapeutics Inc. and bring the company’s peripheral nerve...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...